Amarin Corp Plc (AMRN)

[MNBioMike]

If anyone had a hard time understanding why practice changing medicine (Vascepa) still takes a LONG time to adopt, you can see the recent Twitter string that I posted earlier.

A Mayo Cardiologist fellow, who is at the NLA Fall Conference in Minneapolis was not aware that Vascepa has been included in any guidelines or that Mayo (her own employer) endorsed icosapent ethyl therapy treatment.

This gives you an idea of the ground swell that's coming in the next few years when the targeted docs become more familiar with V and the insurance coverage is a slam dunk.

I plan to head over there shortly to hopefully educate a few more folks before the 7pm session this evening.